{"id":14762,"date":"2021-06-14T11:05:56","date_gmt":"2021-06-14T11:05:56","guid":{"rendered":"https:\/\/clinlabint.com\/?p=14762"},"modified":"2021-06-14T11:05:56","modified_gmt":"2021-06-14T11:05:56","slug":"sphere-fluidics-and-clexbio-introduce-cytrix-microfluidic-hydrogel-kit","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/sphere-fluidics-and-clexbio-introduce-cytrix-microfluidic-hydrogel-kit\/","title":{"rendered":"Sphere Fluidics and ClexBio introduce CYTRIX Microfluidic Hydrogel Kit"},"content":{"rendered":"

\"Sphere<\/p>\n

Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and ClexBio, a pioneer in solutions for tissue engineering and single-cell techniques, have launched the biocompatible\u00a0CYTRIX Microfluidic Hydrogel Kit. The kit combines ClexBio\u2019s novel CYTRIX Hydrogel with Sphere Fluidics\u2019 specially designed Pico-Gen\u2122 double aqueous biochip to allow the plug-and-play generation of defined, reproducible and tailorable hydrogel microstructures for 3D cell culture, organoids, single-cell analysis, and many other applications. This allows researchers to study valuable cells over many weeks rather than days in defined microenvironments that mimic the natural extracellular matrix.<\/p>\n

The CYTRIX Hydrogel overcomes the challenges of existing microfluidic hydrogel formation techniques, such as\u00a0clogging, finicky temperature control or time-critical mixing procedures. It offers cytocompatibility and microfluidic-optimized gelation kinetics, providing researchers with a cell-friendly solution to reduce the effect of harmful temperatures, pH changes and use of UV-light required for existing hydrogel formation techniques. Paired with the Sphere Fluidics Pico-Gen double aqueous biochip and microfluidics, the CYTRIX Hydrogel enables efficient encapsulation of mammalian cells, bacteria, and other microorganisms in a homogeneous and defined extracellular matrix that supports cell viability.<\/p>\n

Dr. Xin Li, Associate Director of Science at Sphere Fluidics said:\u00a0<\/strong>\u201cThe CYTRIX Microfluidic Hydrogel Kit mimics the 3D microenvironment and help researchers explore the potential of hydrogel-based microfluidics in tissue engineering, drug discovery and regenerative medicine over many weeks.\u201d<\/p>\n

Dr. Armend H\u00e5ti, CEO and Co-Founder of ClexBio said:\u00a0<\/strong>\u201cThis exciting collaboration with Sphere Fluidics has enabled us to deliver one of the first commercial solutions that allows simple and cell-friendly formation of cell-laden microgels, lengthening the time that researchers can study the contents of microspheres.\u201d<\/p>\n